Cite
McReynolds CB, Hwang SH, Yang J, et al. Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis. Front Pharmacol. 2019;10:533doi: 10.3389/fphar.2019.00533.
McReynolds, C. B., Hwang, S. H., Yang, J., Wan, D., Wagner, K., Morisseau, C., Li, D., Schmidt, W. K., & Hammock, B. D. (2019). Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis. Frontiers in pharmacology, 10533. https://doi.org/10.3389/fphar.2019.00533
McReynolds, Cindy B, et al. "Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis." Frontiers in pharmacology vol. 10 (2019): 533. doi: https://doi.org/10.3389/fphar.2019.00533
McReynolds CB, Hwang SH, Yang J, Wan D, Wagner K, Morisseau C, Li D, Schmidt WK, Hammock BD. Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis. Front Pharmacol. 2019 May 31;10:533. doi: 10.3389/fphar.2019.00533. eCollection 2019. PMID: 31214021; PMCID: PMC6554663.
Copy
Download .nbib